News
Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until it was removed from the market in 1997 after valvular heart damage and ...
The pulmonary-artery pressure was measured in 31 patients with mitral disease. The predominant lesion in 30 of the patients was mitral stenosis, and in the 1 remaining it was pure mitral ...
The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity constraints that have dogged its core business.
Thus, it is not surprising that patients originally suspected of having mitral ... aortic stenosis we are satisfied that a normal or even accentuated aortic second sound, a wide pulse pressure ...
Blood enters the left ventricle through the mitral valve and leaves through the aortic valve. A stenotic valve is a valve opening that has gotten smaller and is partially obstructing blood flow. In ...
Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) 74th Annual Scientific Session and Expo in Chicago, March 29-31.
This month: shorter recovery after TAVI, Down syndrome CV insights, the benefits of brisker walking, and more.
Edwards Lifesciences Corporation ( NYSE: EW) Q1 2025 Earnings Conference Call April 23, 2025 5:00 PM ET Mark Wilterding - SVP, Global Finance Bernard Zovighian - CEO Scott Ullem - CFO Daveen Chopra - ...
The venous pressure is slightly elevated with easily ... as well as severe symptomatic mitral stenosis, especially when pulmonary hypertension is present. In contrast to regurgitant lesions ...
9d
Zacks Investment Research on MSNSolid TMTT Growth to Drive Edwards Lifesciences' Q1 EarningsEdwards Lifesciences Corp. EW is scheduled to report first-quarter 2025 results on April 23, after the market closes. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results